These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig. Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671 [TBL] [Abstract][Full Text] [Related]
23. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine. Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424 [TBL] [Abstract][Full Text] [Related]
24. Transcriptome Profiling Reveals Degree of Variability in Induced Pluripotent Stem Cell Lines: Impact for Human Disease Modeling. Schuster J; Halvardson J; Pilar Lorenzo L; Ameur A; Sobol M; Raykova D; Annerén G; Feuk L; Dahl N Cell Reprogram; 2015 Oct; 17(5):327-37. PubMed ID: 26348590 [TBL] [Abstract][Full Text] [Related]
25. Identification of the early and late responder genes during the generation of induced pluripotent stem cells from mouse fibroblasts. Park J; Kwon YW; Ham S; Hong CP; Seo S; Choe MK; Shin SI; Lee CS; Kim HS; Roh TY PLoS One; 2017; 12(2):e0171300. PubMed ID: 28152015 [TBL] [Abstract][Full Text] [Related]
26. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential. Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179 [TBL] [Abstract][Full Text] [Related]
28. Metabolomic and Transcriptional Analyses Reveal Atmospheric Oxygen During Human Induced Pluripotent Stem Cell Generation Impairs Metabolic Reprogramming. Spyrou J; Gardner DK; Harvey AJ Stem Cells; 2019 Aug; 37(8):1042-1056. PubMed ID: 31042329 [TBL] [Abstract][Full Text] [Related]
29. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors. Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586 [TBL] [Abstract][Full Text] [Related]
30. The levels of reprogramming factors influence the induction and maintenance of pluripotency: the case of CD1 mouse strain cells. Covarrubias L; Martínez-Sarmiento JÁ; Valencia C; Nagy A; Hernández-García D Int J Dev Biol; 2021; 65(4-5-6):365-376. PubMed ID: 32930373 [TBL] [Abstract][Full Text] [Related]
31. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells. Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079 [TBL] [Abstract][Full Text] [Related]
32. Single-cell sequencing reveals the potential oncogenic expression atlas of human iPSC-derived cardiomyocytes. Ou M; Zhao M; Li C; Tang D; Xu Y; Dai W; Sui W; Zhang Y; Xiang Z; Mo C; Lin H; Dai Y Biol Open; 2021 Feb; 10(2):. PubMed ID: 33589441 [TBL] [Abstract][Full Text] [Related]
33. The Effects of Liu H; Liu Z; Gao M; Hu X; Sun R; Shen X; Liu F; Shen J; Shan Z; Lei L Cell Reprogram; 2020 Apr; 22(2):90-98. PubMed ID: 32150692 [TBL] [Abstract][Full Text] [Related]
35. Molecular and functional resemblance of differentiated cells derived from isogenic human iPSCs and SCNT-derived ESCs. Zhao MT; Chen H; Liu Q; Shao NY; Sayed N; Wo HT; Zhang JZ; Ong SG; Liu C; Kim Y; Yang H; Chour T; Ma H; Gutierrez NM; Karakikes I; Mitalipov S; Snyder MP; Wu JC Proc Natl Acad Sci U S A; 2017 Dec; 114(52):E11111-E11120. PubMed ID: 29203658 [TBL] [Abstract][Full Text] [Related]
36. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4. Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994 [TBL] [Abstract][Full Text] [Related]
37. Bioluminescent imaging of genetically selected induced pluripotent stem cell-derived cardiomyocytes after transplantation into infarcted heart of syngeneic recipients. Lepperhof V; Polchynski O; Kruttwig K; Brüggemann C; Neef K; Drey F; Zheng Y; Ackermann JP; Choi YH; Wunderlich TF; Hoehn M; Hescheler J; Sarić T PLoS One; 2014; 9(9):e107363. PubMed ID: 25226590 [TBL] [Abstract][Full Text] [Related]
38. Strategies for rapidly mapping proviral integration sites and assessing cardiogenic potential of nascent human induced pluripotent stem cell clones. Dambrot C; Buermans HP; Varga E; Kosmidis G; Langenberg K; Casini S; Elliott DA; Dinnyes A; Atsma DE; Mummery CL; Braam SR; Davis RP Exp Cell Res; 2014 Oct; 327(2):297-306. PubMed ID: 24836851 [TBL] [Abstract][Full Text] [Related]
39. Association of Human iPSC Gene Signatures and X Chromosome Dosage with Two Distinct Cardiac Differentiation Trajectories. D'Antonio-Chronowska A; Donovan MKR; Young Greenwald WW; Nguyen JP; Fujita K; Hashem S; Matsui H; Soncin F; Parast M; Ward MC; Coulet F; Smith EN; Adler E; D'Antonio M; Frazer KA Stem Cell Reports; 2019 Nov; 13(5):924-938. PubMed ID: 31668852 [TBL] [Abstract][Full Text] [Related]
40. Reprogramming to pluripotency can conceal somatic cell chromosomal instability. Hamada M; Malureanu LA; Wijshake T; Zhou W; van Deursen JM PLoS Genet; 2012; 8(8):e1002913. PubMed ID: 22952451 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]